Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (107) 107
female (94) 94
index medicus (73) 73
adult (71) 71
breast cancer (67) 67
middle aged (65) 65
mutation (62) 62
oncology (56) 56
cancer (55) 55
genetic aspects (52) 52
breast neoplasms - genetics (50) 50
risk factors (50) 50
genetics & heredity (44) 44
aged (42) 42
genetic predisposition to disease (39) 39
medicin och hälsovetenskap (37) 37
medical and health sciences (36) 36
male (35) 35
women (34) 34
research (33) 33
risk (33) 33
genetics (31) 31
genetic counseling (30) 30
ovarian-cancer (29) 29
brca1 protein - genetics (25) 25
heterozygote (25) 25
medical genetics (25) 25
gene mutations (24) 24
health aspects (24) 24
brca1 (23) 23
cancer och onkologi (22) 22
genes (22) 22
genes, brca2 (22) 22
brca2 protein - genetics (21) 21
cancer and oncology (21) 21
clinical medicine (21) 21
diagnosis (21) 21
genes, brca1 (21) 21
klinisk medicin (21) 21
young adult (21) 21
breast neoplasms - psychology (20) 20
genetic counseling - psychology (20) 20
skin and connective tissue diseases (20) 20
surveys and questionnaires (20) 20
communication (19) 19
polymorphism, single nucleotide (19) 19
brca1 protein (18) 18
families (17) 17
medicine (17) 17
netherlands (17) 17
biomedicine (16) 16
brca2 (16) 16
cancer research (16) 16
genetic testing (16) 16
human genetics (16) 16
ovarian cancer (16) 16
analysis (15) 15
article (15) 15
carriers (15) 15
epidemiology (15) 15
genetic research (15) 15
ovarian neoplasms - genetics (15) 15
public, environmental & occupational health (15) 15
brca2 protein (14) 14
gene (14) 14
genotype (14) 14
germ-line mutation (14) 14
adolescent (13) 13
brca1/2 (13) 13
oncology, experimental (13) 13
prognosis (13) 13
alleles (12) 12
breast neoplasms - diagnosis (12) 12
breast-cancer (12) 12
care and treatment (12) 12
breast (11) 11
cohort (11) 11
cohort studies (11) 11
endocrine system diseases (11) 11
genome-wide association (11) 11
information (11) 11
pedigree (11) 11
susceptibility (11) 11
breast neoplasms (10) 10
deoxyribonucleic acid--dna (10) 10
family-history (10) 10
germline mutations (10) 10
impact (10) 10
phenotype (10) 10
physiological aspects (10) 10
polymorphism (10) 10
population (10) 10
prospective studies (10) 10
surveillance (10) 10
age (9) 9
aged, 80 and over (9) 9
brca2 mutation carriers (9) 9
ethics (9) 9
genetic counselling (9) 9
genetic variation (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
by Milne, Roger L and Kuchenbaecker, Karoline B and Michailidou, Kyriaki and Beesley, Jonathan and Kar, Siddhartha and Lindström, Sara and Hui, Shirley and Lemaçon, Auey and Soucy, Penny and Dennis, Joe and Jiang, Xia and Rostamianfar, Asha and Finucane, Hilary and Bolla, Manjeet K and McGuffog, Lesley and Wang, Qin and Aalfs, Cora M and Adams, Marcia and Adlard, Julian and Agata, Simona and Ahmed, Shahana and Ahsan, Habibul and Aittomäki, Kristiina and Al-Ejeh, Fares and Allen, Jamie and Ambrosone, Christine B and Amos, Christopher I and Anulis, Irene L and Anton-Culver, Hoda and Antonenkova, Natalia N and Arndt, Volker and Arnold, Norbert and Aronson, Kristan J and Auber, Bernd and Auer, Paul L and Ausems, Margreet G. E. M and Azzollini, Jacopo and Bacot, François and Balmaña, Judith and Barile, Monica and Barjhoux, Laure and Barkardottir, Rosa B and Barrdahl, Myrto and Barnes, Daniel and Barrowdale, Daniel and Baynes, Caroline and Beckmann, Matthias W and Benitez, Javier and Bermisheva, Marina and Bernstein, Leslie and Bignon, Yves-Jean and Blazer, Kathleen R and Blok, Marinus J and Blomqvist, Carl and Blot, William and Bobolis, Kristie and Boeckx, Bram and Bogdanova, Natalia V and Bojesen, Anders and Bojesen, Stig E and Bonanni, Bernardo and Børresen-Dale, Anne-Lise and Bozsik, Aniko and Bradbury, Angela R and Brand, Judith S and Brauch, Hiltrud and Brenner, Hermann and Bressac-de Paillerets, Brigitte and Brewer, Carole and Brinton, Louise and Broberg, Per and Brooks-Wilson, Angela and Brunet, Joan and Brüning, Thomas and Burwinkel, Barbara and Buys, Sauna S and Byun, Jinyoung and Cai, Qiuyin and Caldés, Trinidad and Caligo, Maria A and Campbell, Ian and Canzian, Federico and Caron, Olivier and Carracedo, Angel and Carter, Brian D and Castelao, J. Esteban and Castera, Laurent and Caux-Moncoutier, Virginie and Chan, Salina B and Chang-Claude, Jenny and Chanock, Stephen J and Chen, Xiaoqing and Cheng, Ting-Yuan David and Chiquette, Jocelyne and Christiansen, Hans and Claes, Kathleen B. M and Clarke, Christine L and Conner, Thomas and Conroy, Don M and Cook, Jackie and ... and ABCTB Investigators and HEBON and EMBRACE and GEMO Study Collaborators and kConFab AOCS Investigators and NBSC Collaborators and kConFab/AOCS Investigators and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Institutionen för immunologi, genetik och patologi and Medicinsk genetik och genomik and Ortopedi and Uppsala universitet and Institutionen för kirurgiska vetenskaper
Nature genetics, ISSN 1061-4036, 2017, Volume 49, Issue 12, pp. 1767 - 1778
Most common breast cancer susceptibility variants have been identified through genome-wide association studies (GWAS) of predominantly estrogen receptor... 
FUNCTIONAL VARIANTS | COMMON VARIANTS | MODIFIERS | MUTATION CARRIERS | OVARIAN CANCERS | GENETICS & HEREDITY | SUSCEPTIBILITY LOCI | ENHANCER | CONFER SUSCEPTIBILITY | GENOME-WIDE ASSOCIATION | REVEALS | Breast cancer | Genetic aspects | Genetic variation | Health aspects | Risk factors | Disease | BRCA1 protein | Genes | Estrogens | Health risks | Estrogen receptors | Risk | Genomes | Carriers | Consortia | Cell cycle | Breast | Hormone replacement therapy | Mutation | Gene mapping | Health risk assessment | Bioinformatics | Cancer | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
by Couch, Fergus J and Wang, Xianshu and McGuffog, Lesley and Lee, Anew and Olswold, Curtis and Kuchenbaecker, Karoline B and Soucy, Penny and Fredericksen, Zachary and Barrowdale, Daniel and Dennis, Joe and Gaudet, Mia M and Dicks, Ed and Kosel, Matthew and Healey, Sue and Sinilnikova, Olga M and Lee, Adam and Bacot, François and Vincent, Daniel and Hogervorst, Frans B. L and Peock, Susan and Stoppa-Lyonnet, Dominique and Jakubowska, Anna and Radice, Paolo and Schmutzler, Rita Katharina and Domchek, Susan M and Piedmonte, Marion and Singer, Christian F and Friedman, Eitan and Thomassen, Mads and Hansen, Thomas V. O and Neuhausen, Susan L and Szabo, Csilla I and Blanco, Ignacio and Greene, Mark H and Karlan, Beth Y and Garber, Judy and Phelan, Catherine M and Weitzel, Jeffrey N and Montagna, Marco and Olah, Edith and Anulis, Irene L and Godwin, Anew K and Yannoukakos, koulis and Goldgar, David E and Caldes, Trinidad and Nevanlinna, Heli and Osorio, Ana and Terry, Mary Beth and Daly, Mary B and van Rensburg, Elizabeth J and Hamann, Ute and Ramus, Susan J and Toland, Amanda Ewart and Caligo, Maria A and Olopade, Olufunmilayo I and Tung, Nadine and Claes, Kathleen and Beattie, Mary S and Southey, Melissa C and Imyanitov, Evgeny N and Tischkowitz, Marc and Janavicius, Ramunas and John, Esther M and Kwong, Ava and Diez, Orland and Balmaña, Judith and Barkardottir, Rosa B and Arun, Banu K and Rennert, Gad and teo, Soo-Hwang and Ganz, Patricia A and Campbell, Ian and van der Hout, Annemarie H and van Deurzen, Carolien H. M and Seynaeve, Caroline and Gómez Garcia, Encarna B and van Leeuwen, Flora E and Meijers-Heijboer, Hanne E. J and Gille, Johannes J. P and Ausems, Margreet G. E. M and Blok, Marinus J and Ligtenberg, Marjolijn J. L and Rookus, Matti A and Devilee, Peter and Verhoef, Senno and van Os, Theo A. M and Wijnen, Juul T and Frost, Debra and Ellis, Steve and Fineberg, Elena and Platte, Radka and Evans, D. Gareth and Izatt, Louise and Eeles, Rosalind A and Adlard, Julian and Eccles, Diana M and Cook, Jackie and Brewer, Carole and Douglas, Fiona and Hodgson, Shirley and ... and KConFab Investigators and Ontario Canc Genetics Network and EMBRACE and GEMO Study Collaborators and CIMBA and HEBON and BCFR and SWE-BRCA and Ontario Cancer Genetics Network and kConFab Investigators and on behalf of CIMBA and Linköpings universitet and Institutionen för klinisk och experimentell medicin and Onkologi and Hälsouniversitetet
PLoS genetics, ISSN 1553-7390, 2013, Volume 9, Issue 3, p. e1003212
BRCA1-associated breast and ovarian cancer risks can be modified by common genetic variants. To identify further cancer risk-modifying loci, we performed a... 
CONSORTIUM | COMMON VARIANTS | POPULATION | INVESTIGATORS | MODIFIERS | SUBTYPES | SUSCEPTIBILITY ALLELES | GENETICS & HEREDITY | GENETIC-VARIANTS | SELECTION | ZNF365 | Genetic Predisposition to Disease | Genome-Wide Association Study | Prognosis | Humans | Middle Aged | Risk Factors | Ovarian Neoplasms - pathology | Genotype | Ovarian Neoplasms - genetics | BRCA1 Protein - genetics | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Female | Heterozygote | Polymorphism, Single Nucleotide | Mutation | BRCA2 Protein - genetics | Gene mutations | Genomics | Physiological aspects | Breast cancer | Genetic aspects | Research | Risk factors | Ovarian cancer | Cancer | Càncer d'ovari | Càncer de mama | Malalties hereditàries | Genètica humana | Genetic diseases | Human genetics | Life Sciences | Medical and Health Sciences | Medicin och hälsovetenskap | Medical research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis
by Heemskerk-Gerritsen, Bernadette A. M and Rookus, Matti A and Aalfs, Cora M and Ausems, Margreet G. E. M and Collée, Johanna M and Jansen, Liesbeth and Kets, C. Marleen and Keymeulen, Kristien B. M. I and Koppert, Linetta B and Meijers-Heijboer, Hanne E. J and Mooij, Thea M and Tollenaar, Rob A. E. M and Vasen, Hans F. A and Hooning, Maartje J and Seynaeve, Caroline and Rookus, M. A and Hogervorst, F. B. L and van Leeuwen, F. E and Verhoef, S and Schmidt, M. K and de Lange, J. L and Collée, J. M and van den Ouweland, A. M. W and Hooning, M. J and Seynaeve, C and van Deurzen, C. H. M and Obdeijn, I. M and van Asperen, C. J and Wijnen, J. T and Tollenaar, R. A. E. M and Devilee, P and van Cronenburg, T. C. T. E. F and Kets, C. M and Mensenkamp, A. R and Ausems, M. G. E. M and van der Luijt, R. B and van Os, T. A. M and Gille, J. J. P and Waisfisz, Q and Gómez-Garcia, E. B and Blok, M. J and Oosterwijk, J. C and van der Hout, A. H and Mourits, M. J and de Bock, G. H and Vasen, H. F and Siesling, S and Overbeek, L and HEBON
International journal of cancer. Journal international du cancer, ISSN 0020-7136, 2015, Volume 136, Issue 3, pp. 668 - 677
Data on survival of BRCA1/2-associated primary breast cancer (PBC) patients who opt for subsequent contralateral risk-reducing mastectomy (CRRM) are scarce and... 
contralateral risk‐reducing mastectomy | BRCA1/2 | breast cancer | prevention | survival | Prevention | Breast cancer | Contralateral risk-reducing mastectomy | Survival | SURGERY | MORTALITY | contralateral risk-reducing mastectomy | EFFICACY | BRCA1 | OVARIAN-CANCER | WOMEN | PROPHYLACTIC MASTECTOMY | ONCOLOGY | PREDICTORS | FAMILIES | GERMLINE MUTATIONS | OUTCOMES | Breast Neoplasms - surgery | Prospective Studies | Humans | Middle Aged | Breast Neoplasms - genetics | Aged, 80 and over | Genes, BRCA2 | Mastectomy | Adult | Breast Neoplasms - mortality | Female | Aged | Genes, BRCA1 | Mutation | Chemotherapy | Patient outcomes | Surgery | Genetic aspects | Cancer | Surveillance | Health risk assessment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer
by Rebbeck, Timothy R and Mitra, Nandita and Wan, Fei and Sinilnikova, Olga M and Healey, Sue and McGuffog, Lesley and Mazoyer, Sylvie and Chenevix-Trench, Georgia and Easton, Douglas F and Antoniou, Antonis C and Nathanson, Katherine L and Laitman, Yael and Kushnir, Anya and Paluch-Shimon, Shani and Berger, Raanan and Zidan, Jamal and Friedman, Eitan and Ehrencrona, Hans and Stenmark-Askmalm, Marie and Einbeigi, Zakaria and Loman, Niklas and Harbst, Katja and Rantala, Johanna and Melin, Beatrice and Huo, Dezheng and Olopade, Olufunmilayo I and Seldon, Joyce and Ganz, Patricia A and Nussbaum, Robert L and Chan, Salina B and Odunsi, Kunle and Gayther, Simon A and Domchek, Susan M and Arun, Banu K and Lu, Karen H and Mitchell, Gillian and Karlan, Beth Y and Walsh, Christine and Lester, Jenny and Godwin, Andrew K and Pathak, Harsh and Ross, Eric and Daly, Mary B and Whittemore, Alice S and John, Esther M and Miron, Alexander and Terry, Mary Beth and Chung, Wendy K and Goldgar, David E and Buys, Saundra S and Janavicius, Ramunas and Tihomirova, Laima and Tung, Nadine and Dorfling, Cecilia M and van Rensburg, Elizabeth J and Steele, Linda and Neuhausen, Susan L and Ding, Yuan Chun and Ejlertsen, Bent and Gerdes, Anne-Marie and Hansen, Thomas v. O and Ramón y Cajal, Teresa and Osorio, Ana and Benitez, Javier and Godino, Javier and Tejada, Maria-Isabel and Duran, Mercedes and Weitzel, Jeffrey N and Bobolis, Kristie A and Sand, Sharon R and Fontaine, Annette and Savarese, Antonella and Pasini, Barbara and Peissel, Bernard and Bonanni, Bernardo and Zaffaroni, Daniela and Vignolo-Lutati, Francesca and Scuvera, Giulietta and Giannini, Giuseppe and Bernard, Loris and Genuardi, Maurizio and Radice, Paolo and Dolcetti, Riccardo and Manoukian, Siranoush and Pensotti, Valeria and Gismondi, Viviana and Yannoukakos, Drakoulis and Fostira, Florentia and Garber, Judy and Torres, Diana and Rashid, Muhammad Usman and Hamann, Ute and Peock, Susan and Frost, Debra and Platte, Radka and Evans, D. Gareth and Eeles, Rosalind and Davidson, Rosemarie and Eccles, Diana and Cole, Trevor and ... and CIMBA Consortium and Lund University and Division of Clinical Genetics and BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation and Avdelningen för klinisk genetik and Lunds universitet
JAMA, ISSN 0098-7484, 04/2015, Volume 313, Issue 13, pp. 1347 - 1361
IMPORTANCE: Limited information about the relationship between specific mutations in BRCA1 or BRCA2 (BRCA1/2) and cancer risk exists. OBJECTIVE: To identify... 
POSITION | MEDICINE, GENERAL & INTERNAL | UNKNOWN CLINICAL-SIGNIFICANCE | GERMLINE MUTATIONS | SUSCEPTIBILITY GENE | MESSENGER-RNA DECAY | DNA-SEQUENCE VARIANTS | PROTEINS | CARRIERS | MOUSE MODELS | REGION | Genetic Predisposition to Disease | Humans | Middle Aged | Risk Factors | Nucleotides | Ovarian Neoplasms - genetics | Breast Neoplasms - genetics | Age of Onset | Genes, BRCA2 | Adult | Female | Heterozygote | Genes, BRCA1 | Mutation | Women | Usage | BRCA mutations | Breast cancer | Health aspects | Risk factors | Ovarian cancer | Disease prevention | Womens health | Medicinsk genetik | Basic Medicine | Medical Genetics | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Follow-up effects of a tailored pre-counseling website with question prompt in breast cancer genetic counseling
by Albada, Akke and van Dulmen, Sana and Spreeuwenberg, Peter and Ausems, Margreet G E M
Patient Education and Counseling, ISSN 0738-3991, 01/2015, Volume 98, Issue 1, p. 69
Objective: Pre-counseling education helps counselees to prepare for breast cancer genetic counseling and might subsequently result in more positive... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes
by Ruijs, Marielle W. G and Verhoef, Senno and Rookus, Matti A and Pruntel, Roelof and van der Hout, Annemarie H and Hogervorst, Frans B. L and Kluijt, I and Sijmons, Rolf H and Aalfs, Cora M and Wagner, Anja and Ausems, Margreet G. E. M and Hoogerbrugge, Nicoline and van Asperen, Christi J and Gomez Garcia, Encarna B and Meijers-Heijboer, Hanne and ten Kate, Leo P and Menko, Fred H and van 't Veer, Laura J
Journal of medical genetics, ISSN 0022-2593, 2010, Volume 47, Issue 6, pp. 421 - 428
BACKGROUND Li-Fraumeni syndrome (LFS) is a rare autosomal dominant cancer predisposition syndrome. Most families fulfilling the classical diagnostic criteria... 
BREAST-CANCER | P53 MUTATIONS | CRITERIA | GENE | NEOPLASMS | SARCOMAS | TISSUE | GENETICS & HEREDITY | RISK | TUMORS | CARCINOMA | Colonic Neoplasms - genetics | Pancreatic Neoplasms - diagnosis | Humans | Middle Aged | Colonic Neoplasms - diagnosis | Family Health | Male | Neoplasms - diagnosis | Li-Fraumeni Syndrome - diagnosis | Genetic Testing - methods | Tumor Suppressor Protein p53 - genetics | Young Adult | Li-Fraumeni Syndrome - genetics | Netherlands | Neoplasms - genetics | DNA Mutational Analysis | Germ-Line Mutation | Adult | Female | Genetic Predisposition to Disease | Gene Frequency | Risk Factors | Genotype | Pancreatic Neoplasms - genetics | Phenotype | Gene mutations | DNA | Analysis | Physiological aspects | Genetic aspects | Research | Risk factors | Li-Fraumeni syndrome | Liver cancer | Brain cancer | Pancreatic cancer | Colorectal cancer | Melanoma | Breast cancer | Mutation | Age | Deoxyribonucleic acid--DNA | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations
by Brohet, Richard M and Velthuizen, Maria E and Hogervorst, Frans B L and EJ Meijers-Heijboer, Hanne and Seynaeve, Caroline and Collée, Margriet J and Verhoef, Senno and Ausems, Margreet G E M and Hoogerbrugge, Nicoline and van Asperen, Christi J and Gómez García, Encarna and Menko, Fred and Oosterwijk, Jan C and Devilee, Peter and Veer, Laura J van't and van Leeuwen, Flora E and Easton, Douglas F and Rookus, Matti A and Antoniou, Antonis C and HEBON Resource
Journal of Medical Genetics, ISSN 0022-2593, 02/2014, Volume 51, Issue 2, pp. 98 - 107
Background BRCA1 or BRCA2 mutations confer increased risks of breast and ovarian cancer, but risks have been found to vary across studies and populations.... 
POPULATION | PENETRANCE | POSITION | GENOMIC DELETIONS | CUMULATIVE RISK | GENETICS & HEREDITY | GERMLINE MUTATIONS | SUSCEPTIBILITY GENE | LINKAGE ANALYSIS | PREVALENCE | CARRIERS | Hereditary Breast and Ovarian Cancer Syndrome - genetics | Age Distribution | Humans | Middle Aged | Netherlands - epidemiology | Risk | Young Adult | Founder Effect | Pedigree | Age of Onset | Genes, BRCA2 | Adult | Female | Aged | Hereditary Breast and Ovarian Cancer Syndrome - epidemiology | Genes, BRCA1 | Mutation | Cohort Studies | Influence | Breast cancer | Gene mutations | Risk factors | Ovarian cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study
by Bancroft, Elizabeth K and Page, Elizabeth C and Castro, Elena and Lilja, Hans and Vickers, Andrew and Sjoberg, Daniel and Assel, Melissa and Foster, Christopher S and Mitchell, Gillian and Drew, Kate and Mæhle, Lovise and Axcrona, Karol and Evans, D. Gareth and Bulman, Barbara and Eccles, Diana and McBride, Donna and van Asperen, Christi and Vasen, Hans and Kiemeney, Lambertus A and Ringelberg, Janneke and Cybulski, Cezary and Wokolorczyk, Dominika and Selkirk, Christina and Hulick, Peter J and Bojesen, Anders and Skytte, Anne-Bine and Lam, Jimmy and Taylor, Louise and Oldenburg, Rogier and Cremers, Ruben and Verhaegh, Gerald and van Zelst-Stams, Wendy A and Oosterwijk, Jan C and Blanco, Ignacio and Salinas, Monica and Cook, Jackie and Rosario, Derek J and Buys, Saundra and Conner, Tom and Ausems, Margreet G and Ong, Kai-ren and Hoffman, Jonathan and Domchek, Susan and Powers, Jacquelyn and Teixeira, Manuel R and Maia, Sofia and Foulkes, William D and Taherian, Nassim and Ruijs, Marielle and den Enden, Apollonia T. Helderman-van and Izatt, Louise and Davidson, Rosemarie and Adank, Muriel A and Walker, Lisa and Schmutzler, Rita and Tucker, Kathy and Kirk, Judy and Hodgson, Shirley and Harris, Marion and Douglas, Fiona and Lindeman, Geoffrey J and Zgajnar, Janez and Tischkowitz, Marc and Clowes, Virginia E and Susman, Rachel and Ramón y Cajal, Teresa and Patcher, Nicholas and Gadea, Neus and Spigelman, Allan and van Os, Theo and Liljegren, Annelie and Side, Lucy and Brewer, Carole and Brady, Angela F and Donaldson, Alan and Stefansdottir, Vigdis and Friedman, Eitan and Chen-Shtoyerman, Rakefet and Amor, David J and Copakova, Lucia and Barwell, Julian and Giri, Veda N and Murthy, Vedang and Nicolai, Nicola and Teo, Soo-Hwang and Greenhalgh, Lynn and Strom, Sara and Henderson, Alex and McGrath, John and Gallagher, David and Aaronson, Neil and Ardern-Jones, Audrey and Bangma, Chris and Dearnaley, David and Costello, Philandra and Eyfjord, Jorunn and Rothwell, Jeanette and Falconer, Alison and Gronberg, Henrik and Hamdy, Freddie C and ... and IMPACT Collaborators and Clinical Chemistry, Malmö and Klinisk kemi, Malmö and EpiHealth: Epidemiology for Health and Lund University and Lunds universitet
European Urology, ISSN 0302-2838, 2014, Volume 66, Issue 3, pp. 489 - 499
Abstract Background Men with germline breast cancer 1, early onset ( BRCA1 ) or breast cancer 2, early onset ( BRCA2 ) gene mutations have a higher risk of... 
Urology | Targeted screening | BRCA1 | BRCA2 | Prostate-specific antigen | Prostate cancer | MORTALITY | SURVIVAL | POPULATION | RANDOMIZED PROSTATE | BIOPSY | RISK | PREVALENCE | FAMILY-HISTORY | MEN | UROLOGY & NEPHROLOGY | ANTIGEN | Predictive Value of Tests | Prostatic Neoplasms - pathology | Genetic Predisposition to Disease - genetics | Early Detection of Cancer | Humans | Middle Aged | Genotype | Male | Prostate-Specific Antigen - blood | Patient Selection | Prostate - pathology | Prostatic Neoplasms - genetics | Biopsy | Genes, BRCA2 | Prostatic Neoplasms - blood | Adult | Aged | Genes, BRCA1 | Mutation | Genetic aspects | Diagnosis | Gene mutations | Cancer | Platinum Priority – Prostate Cancer | Urologi och njurmedicin | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Urology and Nephrology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Am I my Family's Keeper? : Disclosure Dilemmas in Next Generation Sequencing
by Wouters, Roel H P and Bijlsma, Rhodé M and Ausems, Margreet G E M|info:eu-repo/dai/nl/18756969X and van Delden, Johannes J M|info:eu-repo/dai/nl/086541331 and Voest, Emile E and Bredenoord, Annelien L|info:eu-repo/dai/nl/240834666
Human Mutation, ISSN 1059-7794, 09/2016, Volume 37, Issue 12, pp. 1257–1262 - 1262
Ever since genetic testing is possible for specific mutations, ethical debate has sparked on the question of whether professionals have a duty to warn not only... 
unsolicited finding | moral accountability nudge | NGS | ethics | next‐generation sequencing | libertarian paternalism | next-generation sequencing | MEMBERS | GENETIC INFORMATION | WARN | CARE | AT-RISK RELATIVES | DUTY | GENETICS & HEREDITY | CANCER-RISK | COMMUNICATION | PARTICIPANTS | Humans | Moral Obligations | Incidental Findings | Disclosure - ethics | Family | Professional Role | High-Throughput Nucleotide Sequencing - ethics | Disease susceptibility | Psychiatric services | Genetic screening | Informed consent | Duty to warn | Genetic testing | Mutation | Patients
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights